Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
A fall in global oil prices following a fragile truce between the United States and Iran has reduced short-term inflationary pressure in many emerging economies. Analysts warn, however, that months of elevated energy costs have already strained household budgets and that lower wholesale prices will take time to reach consumers. Governments face har…
Bloom Energy shares fell more than 10% in morning trading to $276.16, reversing sharply from a 52-week high set the previous session. The decline follows an extraordinary 12-month gain of over 1,300% and reflects a mix of competitive developments, valuation skepticism and insider selling. Short-seller commentary, a Barclays price-target reset and g…
Equity markets on Friday featured wide intraday moves across market-cap tiers. Large-cap technology names and a cluster of small- and mid-cap healthcare and industrial stocks recorded both sharp gains and steep declines. Company-specific reports and regulatory developments underpinned the largest percentage changes.
The U.S. Department of the Treasury announced sanctions on eight individuals and entities tied to procurement and recruitment networks supporting the warring parties in Sudan. The Office of Foreign Assets Control targeted firms and people linked to the Sudanese Armed Forces and the paramilitary Rapid Support Forces, citing the humanitarian toll of …
National CineMedia, Inc. (NASDAQ: NCMI) Chief Financial Officer Ronnie Y. Ng executed a sale of 19,000 shares of company common stock on June 22, 2026, with total proceeds reaching $64,947. The transaction, conducted through an open market sale under a Rule 10b5-1 trading plan adopted on March 20, 2026, resulted in an average sale price of $3.4183 …
We upgrade Amazon to a buy and recommend a swing trade entry at current levels. Macroeconomic improvement and accelerating AI monetization — including potential external sales of Trainium chips — support upside to $265 over the next ~45 trading days. Valuation, healthy profitability metrics, and a manageable balance sheet provide a buffer despite n…
ServiceNow shares climbed sharply in morning trading after a high-profile alliance tying the company more closely into an expanding enterprise AI ecosystem. The stock rose 7.3% to $96.04 from a prior close of $89.52, drawing buyers into a name that had been heavily sold. The immediate trigger was a three-way agreement announced the prior session th…
Backblaze (BLZE) has shed its dormant label and is seeing a fresh re-rate driven by AI customer growth, improving margins and guidance toward positive adjusted free cash flow in H2 2026. The technical breakout and low days-to-cover shorts add momentum, but legal questions and high valuation metrics require disciplined risk management. We recommend …
Palantir Technologies climbed 4.5% in morning trading after investor Michael Burry disclosed that he closed half of his short position. The move removed a visible overhang on the stock and coincided with new commercial agreements, including a seven-year tie-up with Zeta Global and a potential up-to-$12 million deployment with Surf Air Mobility and …
Five Star Bancorp (FSBC) is a compact Northern California regional bank with above-average returns, a modest valuation at current earnings, and a concentrated CRE and agribusiness lending strategy that is being scaled carefully. We propose a long trade with entry at $47.92, target $60.00 and stop loss $42.00 over a long-term (180 trading days) hori…
Eli Lilly shares climbed sharply after the European Medicines Agency’s CHMP issued a favorable opinion for Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia and the company published Medicare GLP-1 Bridge Program guidance that would allow eligible Medicare Part D patients access to Zepbound and Foundayo for $50 per month. An analyst price-ta…
Amazon is investing aggressively in AI infrastructure across AWS, custom silicon, and logistics. These investments temporarily pressure free cash flow but reinforce a competitive moat that can drive higher AWS margins, a new AI-chip revenue stream, and stronger ad monetization. The trade: initiate a long on AMZN at $231.28 with a $270 target over 1…
Netflix shares climbed about 5.0% in morning trading after tumbling to a new 52-week low in the prior session. The rebound reflects value-driven buying, supportive analyst commentary, and recent content and distribution agreements, even as the company faces lingering concerns about revenue guidance and its share of streaming time. Q2 2026 results d…
ServiceNow stock rose 6.8% in morning trading after the company announced a three-way AI partnership with HCLTech and Google Cloud designed to accelerate enterprise AI agents from pilot projects into production across field services, manufacturing, customer experience and IT operations. The deal bolsters ServiceNow's growing list of AI collaborator…
Microsoft shares climbed about 4.0% in morning trading, recovering from a 52-week low hit the prior session as value-oriented investors purchased the stock following a sharp pullback. The drop had been triggered by EU regulatory scrutiny of Azure under the Digital Markets Act and ongoing concerns about AI infrastructure costs. Analysts largely pres…
ANI Pharmaceuticals is growing into a rare-disease specialty story while still generating generics cash flow. The company reported record 2025 revenue of $883.4M (up 43.8% YoY) and is guiding to >$1B in 2026. At a market cap near $1.93B and a P/E ~21, the stock trades like a generics mid-cap despite rare-disease growth driving margin expansion and …
Nextpower Inc (NASDAQ:NXT) shares declined 4.2% on Friday after Jefferies reduced its price target to $153 from $159 while retaining a Buy rating. Jefferies analyst Julian Dumoulin-Smith cited a negative market reaction to the company's latest mergers and acquisitions and growing investor questions about strategic direction. Despite the lower price…
A Jefferies survey of 40 IT executives found Microsoft, Amazon Web Services, Palo Alto Networks and ServiceNow to be the most favored software and services providers heading into 2026. The report also highlights accelerating software budget expectations, widespread dedicated AI budgets and a notably negative read-through for Adobe amid AI-related p…
A University of Michigan survey found U.S. consumer sentiment rose in June to a final reading of 49.5 from 44.8 in May, signaling a modest recovery from recent lows. Despite the uptick, more than half of households continued to cite high prices as a drag on personal finances, and inflation expectations remain above pre-crisis norms over the next ye…
Veeva Systems (VEEV) remains one of the highest-quality vertical SaaS franchises: recurring subscription growth, strong free cash flow, and a pristine balance sheet. Recent beats and raised FY2027 guidance validate the business, but the stock has been volatile and still trades well off its 52-week peak. This trade idea offers a structured long with…
Cognition Therapeutics (CGTX) has tangible clinical progress and a clearer path to Phase 3 for CT1812 (zervimesine), supported by a $30M registered direct offering last year. At a market cap near $102M and a current price of $1.145, the stock offers upside if Phase 3 plans and regulatory interactions check boxes; downside is dominated by funding ne…
Joseph Burns Rhame III, an officer of the investment advisor for the Reaves Utility Income Fund, executed a direct purchase of 500 shares of the fund's stock on June 26, 2026. The transaction occurred at $41.20 per share, totaling $20,600. This acquisition increases his direct ownership stake in the utility-focused investment vehicle. The purchase …
Incyte Corporation stock rose after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis when topical corticosteroids and topical calcineurin inhibitors are inadequate or inappropriate. The recommendat…
John Bolton, who served as national security adviser during President Donald Trump’s first term and has since become a prominent critic, is expected to plead guilty to charges of mishandling classified information. Under a reported plea agreement, Bolton would face a sentencing range from no prison time to up to five years, and would pay a $2.25 mi…
The Boston Beer Company’s Truly Hard Seltzer is backing the U.S. Men’s National Soccer Team with a $5 million prize for a fan if the team wins the summer tournament. The campaign, part of Truly’s 'Drink Like a Believer' initiative, includes social media contests and limited-edition product packs celebrating U.S. Soccer fandom. This marketing effort…
